Pharmacy Compounding: Second Draft Of FDA Compliance Guide Coming Soon
FDA is likely to issue a second draft of its pharmacy compounding compliance policy guide before issuing a final policy
You may also be interested in...
FDA is returning to the drug compounding policy laid out in a 1992 compliance policy guide in response to a recent Supreme Court decision
The Supreme Court decision overturning restrictions on advertising of compounded drugs suggests that any moves by Congress to control direct-to-consumer advertising will face a close, skeptical review in court
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011